Overview

Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy

Status:
Completed

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The aim of this pilot study is to determine if there are any changes in brain glucose metabolism in the gray matter of patients with Phenylketonuria (PKU) and whether administration of Sapropterin (KUVAN) therapy can improve such deficits.

Phase:

N/A

Details

Lead Sponsor:

Children's Hospital of Philadelphia

Treatments:

Deoxyglucose
Verapamil